Organization
Kaiser Permanente National Drug Use Management
1 abstract
Abstract
Outcomes of reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer.Org: Kaiser Permanente San Diego, Kaiser Permanente National Drug Use Management,